Granules India Limited (GRANULES.NS)
INR 444.35
(1.71%)
INR 444.35
(1.71%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 55.2 Billion INR | 12.57% |
| 2022 | 49.04 Billion INR | 8.68% |
| 2021 | 45.12 Billion INR | 21.53% |
| 2020 | 37.13 Billion INR | 12.48% |
| 2019 | 33.01 Billion INR | 10.68% |
| 2018 | 29.82 Billion INR | 12.82% |
| 2017 | 26.43 Billion INR | 40.9% |
| 2016 | 18.76 Billion INR | 29.15% |
| 2015 | 14.52 Billion INR | 21.36% |
| 2014 | 11.97 Billion INR | 20.68% |
| 2013 | 9.92 Billion INR | 45.3% |
| 2012 | 6.82 Billion INR | 19.5% |
| 2011 | 5.71 Billion INR | 31.38% |
| 2010 | 4.34 Billion INR | 5.56% |
| 2009 | 4.11 Billion INR | 1.78% |
| 2008 | 4.04 Billion INR | 8.8% |
| 2007 | 3.72 Billion INR | 12.66% |
| 2006 | 3.3 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 52.64 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 55.2 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 55.2 Billion INR | 12.57% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 49.04 Billion INR | 8.68% |
| 2022 Q2 | 48.58 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 49.04 Billion INR | 0.0% |
| 2021 FY | 45.12 Billion INR | 21.53% |
| 2021 Q2 | 41.19 Billion INR | 0.0% |
| 2021 Q4 | 45.12 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 37.13 Billion INR | 12.48% |
| 2020 Q4 | 37.13 Billion INR | 0.0% |
| 2020 Q2 | 34.88 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q2 | 31.71 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 33.01 Billion INR | 10.68% |
| 2019 Q4 | 33.01 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q4 | 29.82 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 29.5 Billion INR | 0.0% |
| 2018 FY | 29.82 Billion INR | 12.82% |
| 2017 Q2 | 24.19 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 26.43 Billion INR | 40.9% |
| 2017 Q4 | 26.43 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 18.76 Billion INR | 0.0% |
| 2016 FY | 18.76 Billion INR | 29.15% |
| 2016 Q2 | 16.13 Billion INR | 0.0% |
| 2015 Q4 | 14.52 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 FY | 14.52 Billion INR | 21.36% |
| 2015 Q2 | 12.66 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q2 | 11.06 Billion INR | 0.0% |
| 2014 FY | 11.97 Billion INR | 20.68% |
| 2014 Q4 | 11.97 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2013 Q2 | 8.35 Billion INR | 0.0% |
| 2013 Q4 | 9.92 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 9.92 Billion INR | 45.3% |
| 2012 FY | 6.82 Billion INR | 19.5% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q4 | 6.82 Billion INR | 0.0% |
| 2012 Q2 | 11.71 Billion INR | 0.0% |
| 2011 FY | 5.71 Billion INR | 31.38% |
| 2010 FY | 4.34 Billion INR | 5.56% |
| 2009 FY | 4.11 Billion INR | 1.78% |
| 2008 FY | 4.04 Billion INR | 8.8% |
| 2007 FY | 3.72 Billion INR | 12.66% |
| 2006 FY | 3.3 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aarti Drugs Limited | 24.32 Billion INR | -126.98% |
| Albert David Limited | 4.97 Billion INR | -1008.65% |
| Alembic Limited | 23.28 Billion INR | -137.077% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -11626.137% |
| Hester Biosciences Limited | 6.62 Billion INR | -733.548% |
| Hikal Limited | 24.87 Billion INR | -121.981% |
| Ind-Swift Limited | 6.54 Billion INR | -743.579% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -2199.819% |
| Unichem Laboratories Limited | 31.69 Billion INR | -74.2% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 14.345% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -3638.436% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -621.577% |
| Brooks Laboratories Limited | 904.45 Million INR | -6004.215% |
| Eris Lifesciences Limited | 70.48 Billion INR | 21.675% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | -135.276% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -2443.317% |
| Wanbury Limited | 3.43 Billion INR | -1507.305% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | -113.818% |
| Alkem Laboratories Limited | 155.74 Billion INR | 64.552% |
| FDC Limited | 24.68 Billion INR | -123.695% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | -93.691% |
| Gufic Biosciences Limited | 10.92 Billion INR | -405.334% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -373.861% |
| Innova Captab Limited | 13.2 Billion INR | -317.977% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -145.989% |
| Ipca Laboratories Limited | 111.01 Billion INR | 50.267% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 52.193% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -688.385% |
| Lupin Limited | 239.97 Billion INR | 76.993% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -1555.843% |
| Medico Remedies Limited | 961.95 Million INR | -5639.347% |
| Morepen Laboratories Limited | 12.93 Billion INR | -326.922% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -151.978% |
| Orchid Pharma Limited | 15.53 Billion INR | -255.304% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -595.023% |
| RPG Life Sciences Limited | 5.12 Billion INR | -976.488% |
| Sigachi Industries Limited | 6.94 Billion INR | -695.351% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 93.54% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | -144.932% |
| Themis Medicare Limited | 5.66 Billion INR | -874.721% |
| Vaishali Pharma Limited | 799.55 Million INR | -6805.051% |
| Venus Remedies Limited | 6.26 Billion INR | -780.778% |
| Windlas Biotech Limited | 6.26 Billion INR | -781.656% |
| ZIM Laboratories Limited | 4.46 Billion INR | -1135.61% |
| Sakar Healthcare Limited | 3.88 Billion INR | -1320.52% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 87.751% |
| Divi's Laboratories Limited | 154.7 Billion INR | 64.312% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -412.137% |
| Mankind Pharma Limited | 119.63 Billion INR | 53.851% |
| Sequent Scientific Limited | 15.4 Billion INR | -258.416% |
| Laurus Labs Limited | 83.87 Billion INR | 34.172% |
| Neuland Laboratories Limited | 18.32 Billion INR | -201.271% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | -38.227% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 61.549% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 81.145% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -1404.885% |
| Wockhardt Limited | 76.49 Billion INR | 27.821% |
| Bal Pharma Limited | 3.2 Billion INR | -1623.212% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 85.753% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -354.825% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -5333.444% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | -104.679% |
| Shilpa Medicare Limited | 30.93 Billion INR | -78.487% |
| Valiant Laboratories Limited | 3.42 Billion INR | -1511.085% |
| Ajanta Pharma Limited | 46.38 Billion INR | -19.028% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -1710.205% |
| Medicamen Biotech Limited | 2.94 Billion INR | -1774.554% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -1264.338% |
| Piramal Enterprises Limited | 826.05 Billion INR | 93.316% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 63.343% |
| NATCO Pharma Limited | 69.06 Billion INR | 20.059% |
| Suven Life Sciences Limited | 2.84 Billion INR | -1837.848% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -2998.634% |
| Strides Pharma Science Limited | 58.39 Billion INR | 5.459% |
| Indoco Remedies Limited | 21.44 Billion INR | -157.421% |
| Alpa Laboratories Limited | 1.82 Billion INR | -2923.18% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -3559.462% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -971.952% |